Research programme: brain aminopeptidase A inhibitors - Quantum Genomics

Drug Profile

Research programme: brain aminopeptidase A inhibitors - Quantum Genomics

Alternative Names: QGC-006

Latest Information Update: 01 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Quantum Genomics
  • Class Amines; Disulfides; Sulfonic acids
  • Mechanism of Action Glutamyl aminopeptidase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Research Hypertension

Most Recent Events

  • 29 Aug 2016 Early research in Hypertension in France before August 2016 (Quantum Genomics pipeline, August 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top